Naciye Cigdem Arslan1, Gulsen Atasoy2, Tansu Altintas3, Cem Terzi4. 1. Department of General Surgery, Medipol University, Birlik mah Bahceler cd 5, 34230, Istanbul, Turkey. cigdemarslan@hotmail.it. 2. Department of General Surgery, Gokceada State Hospital, 17760, Canakkale, Turkey. 3. Department of General Surgery, Kanuni SS Research Hospital, 34303, Istanbul, Turkey. 4. Department General Surgery, Bogazici Academy of Clinical Sciences, 34357, Istanbul, Turkey.
Abstract
PURPOSE: The aim of this study is to investigate the effect of triclosan-coated sutures on surgical site infections after wide excision and primary closure for pilonidal disease. METHODS:One hundred seventy-seven patients were randomized into two groups: 91 in control and 86 in triclosan groups. In the control group, 1/0 monofilament polypropylene retention sutures, 3/0 polyglactin subcutaneous sutures, and 3/0 polypropylene skin sutures were used. In the triclosan group, 1/0 triclosan-coated monofilament polydioxanone, 3/0 triclosan-coated polyglactin, and 3/0 triclosan-coated monofilament polydioxanone were used. Postoperative care and follow-up was made by a surgeon according to Centers for Disease Control guideline. Surgical site infection rates between groups were compared. Secondary outcomes were seroma and wound dehiscence. RESULTS:Seroma was seen in 30 (16.9%) patients: 20 (23.3%) in the triclosan group and 10 (10.9%) in the control group (p = 0.030). Thirteen (7.3%) patients had superficial wound dehiscence: 5 (5.5%) patients in the control group and 10 (11.6%) patients in the triclosan group (p = 0.116). Overall surgical site infection (SSI) rate was 15.8% (n = 28): 19 (20.8%) patients in the control group and 9 (10.5%) patients in the triclosan group (p = 0.044). Healing was observed on mean 17.8 ± 6.7 days. Primary and secondary healing rates and time to healing were similar between groups. CONCLUSION:Triclosan-coated sutures decreased surgical site infection rate but had no effect on time to healing in pilonidal disease. Seroma and wound dehiscence were more common in triclosan groups. Randomized trials are needed to clear the effect of triclosan-coated sutures on postoperative wound complications.
RCT Entities:
PURPOSE: The aim of this study is to investigate the effect of triclosan-coated sutures on surgical site infections after wide excision and primary closure for pilonidal disease. METHODS: One hundred seventy-seven patients were randomized into two groups: 91 in control and 86 in triclosan groups. In the control group, 1/0 monofilament polypropylene retention sutures, 3/0 polyglactin subcutaneous sutures, and 3/0 polypropylene skin sutures were used. In the triclosan group, 1/0 triclosan-coated monofilament polydioxanone, 3/0 triclosan-coated polyglactin, and 3/0 triclosan-coated monofilament polydioxanone were used. Postoperative care and follow-up was made by a surgeon according to Centers for Disease Control guideline. Surgical site infection rates between groups were compared. Secondary outcomes were seroma and wound dehiscence. RESULTS:Seroma was seen in 30 (16.9%) patients: 20 (23.3%) in the triclosan group and 10 (10.9%) in the control group (p = 0.030). Thirteen (7.3%) patients had superficial wound dehiscence: 5 (5.5%) patients in the control group and 10 (11.6%) patients in the triclosan group (p = 0.116). Overall surgical site infection (SSI) rate was 15.8% (n = 28): 19 (20.8%) patients in the control group and 9 (10.5%) patients in the triclosan group (p = 0.044). Healing was observed on mean 17.8 ± 6.7 days. Primary and secondary healing rates and time to healing were similar between groups. CONCLUSION:Triclosan-coated sutures decreased surgical site infection rate but had no effect on time to healing in pilonidal disease. Seroma and wound dehiscence were more common in triclosan groups. Randomized trials are needed to clear the effect of triclosan-coated sutures on postoperative wound complications.
Authors: Markus K Diener; Phillip Knebel; Meinhard Kieser; Philipp Schüler; Tobias S Schiergens; Vladimir Atanassov; Jens Neudecker; Erwin Stein; Henryk Thielemann; Reiner Kunz; Moritz von Frankenberg; Utz Schernikau; Jörg Bunse; Boris Jansen-Winkeln; Lars I Partecke; Gerald Prechtl; Julius Pochhammer; Ralf Bouchard; René Hodina; K Tobias E Beckurts; Lothar Leißner; Hans-Peter Lemmens; Friedrich Kallinowski; Oliver Thomusch; Daniel Seehofer; Thomas Simon; Alexander Hyhlik-Dürr; Christoph M Seiler; Thilo Hackert; Christoph Reissfelder; René Hennig; Colette Doerr-Harim; Christina Klose; Alexis Ulrich; Markus W Büchler Journal: Lancet Date: 2014-04-07 Impact factor: 79.321
Authors: V K Stauffer; M M Luedi; P Kauf; M Schmid; M Diekmann; K Wieferich; B Schnüriger; D Doll Journal: Sci Rep Date: 2018-02-15 Impact factor: 4.379
Authors: X Wu; N Z Kubilay; J Ren; B Allegranzi; P Bischoff; B Zayed; D Pittet; J Li Journal: Eur J Clin Microbiol Infect Dis Date: 2016-09-02 Impact factor: 3.267
Authors: Imran Ahmed; Adam Jonathan Boulton; Sana Rizvi; William Carlos; Edward Dickenson; N A Smith; Mike Reed Journal: BMJ Open Date: 2019-09-03 Impact factor: 2.692
Authors: Manuel Bustamante Montalvo; Miguel Cainzos; Luis Prieto Carreiras; Andrea Castiñeira Piñeiro; Adrián García Iglesias; Ana Fernandez Novo; Lara María González Gómez; Ana Flores; Rita Diz Gil; Carlos Fernández Baltar Journal: Infect Prev Pract Date: 2021-06-07